China Securities Litigation: Recovering Losses from Chinese Listed Companies for Foreign Investors

The following is general information on Chinese law, not legal advice for any specific matter. The Securities Law and the judicial interpretations that apply to it change from time to time, and the treatment of any claim depends on its facts; consult qualified PRC counsel before acting.

The governing statute: the 2019 Securities Law

The foundation of a securities misrepresentation claim in China is the PRC Securities Law, revised on 28 December 2019 and effective 1 March 2020. The revision replaced the previous regime in important respects, and it is the starting point for any foreign investor — including a QFII, a Stock Connect participant or an offshore fund — that has suffered a loss on a Chinese listed company and wants to understand who can be held responsible. The investor's nationality does not change the analysis: the question is whether the loss was caused by a false record, a misleading statement or a material omission in the issuer's disclosure, and who was behind it.

Article 85: who bears the loss

Article 85 is the liability provision that matters. Where disclosure documents — offering documents, periodic reports, ad hoc announcements and other information disclosed by the company — contain false records, misleading statements or material omissions that cause investor losses, the disclosure obligor is liable, and the controlling shareholders, actual controllers, directors, supervisors and senior management, together with other directly responsible persons, bear joint and several liability. Crucially, the article also reaches the gatekeepers: sponsors (保荐人) and the underwriting securities firms (承销的证券公司) and their directly responsible persons are likewise jointly and severally liable. The burden is reversed — a defendant escapes only by proving it was not at fault. This is the successor to Article 69 of the 2014 version of the law, and the difference is that the net of responsible parties is now wider and the presumption of fault is explicit.

Article 95(3): the special representative action

The 2019 revision also created the most distinctive tool in Chinese securities litigation: the special representative action under Article 95, paragraph 3. Where an investor protection institution is entrusted by fifty or more investors, it may act as the representative and register the rights-holders confirmed by the securities depository and clearing institution, and the action operates on an opt-out basis — every investor in the confirmed class is bound unless they expressly state that they do not wish to join. The institution behind this mechanism is the China Securities Investor Services Center (中证中小投资者服务中心, CSISC), one of the two statutory investor protection institutions, which brought China's first special representative action in the Kangmei Pharmaceutical (康美药业) case before the Guangzhou Intermediate People's Court in 2021. For a foreign holder, the practical meaning is that losses too small to justify an individual action can be aggregated and pursued collectively.

The limitation period: three years, not two

One point is frequently misstated. The current limitation period for securities misrepresentation claims is three years, under Article 188 of the Civil Code, running from the exposure date or the correction date (揭露日 or 更正日) as determined under the Supreme People's Court's 2022 judicial interpretation on securities misrepresentation (法释〔2022〕2号, effective 22 January 2022, Article 32). The older two-year period came from the superseded 2003 interpretation (法释〔2003〕2号) and is no longer the rule. The distinction is not academic: because the limitation period runs from exposure or correction rather than from the purchase, and because a pending regulatory investigation can affect the running of time, a foreign investor should establish the operative dates early rather than assume the claim is time-barred or safe.

How a foreign investor should proceed

• Identify the disclosure event. Pin down the false record, misleading statement or omission and the exposure or correction date, which anchors liability and the limitation period.
• Map the responsible parties. The issuer, controlling shareholders, actual controllers, directors and the sponsor and underwriters can all be in the frame under Article 85.
• Check for a pending administrative penalty or criminal judgment. A CSRC penalty or a criminal judgment is strong but not indispensable evidence of misrepresentation.
• Consider the special representative route. Where the claim is modest, aggregation through an investor protection institution may be the efficient path.
• Move within three years. Confirm the operative exposure or correction date and act within the limitation period.

The liability rules, the interpretation and the limitation period are applied by the courts on the latest official basis and on the facts of each case; the summary above is general information current as of the date of writing. For the enforcement dimension that often follows a judgment, see our guide to China antitrust and SAMR investigations, and for the foreign-investment rules that frame a securities holding, see China's foreign investment security review.